Q-omics provides the consensus-scored MIR3672 profile across patient tissues and cancer cell-line models. MIR3672 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in LUAD. Among the 18 cancer types available for tumor–normal comparison, MIR3672 is differentially expressed in 1, with the highest sampling consensus in STAD. Additionally, MIR3672 RNA expression shows 6,002 significant gene co-expression associations, with the highest sampling consensus in UCEC. Together, these results highlight LUAD, STAD, and UCEC as cancer lineages where MIR3672 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR3672 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR3672 survival associations across molecular data types. MIR3672 RNA expression shows survival associations in the most cancer types (7). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR3672 RNA expression–survival associations across cancer types. High MIR3672 expression shows unfavorable associations in LUAD, LAML, KIRC, SARC and UCEC, but favorable associations in ESCA. The LUAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LUAD as the clearest survival context for MIR3672 RNA expression.
This table summarizes MIR3672 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in STAD for RNA.
This table ranks reproducible tumor–normal expression differences for MIR3672. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR3672 shows higher tumor expression in STAD. The STAD box plot shows higher MIR3672 RNA expression in tumor versus normal tissue (log2 FC = +0.182, t-test p = .032).
This table shows molecular features associated with MIR3672 in patient tissues and cancer cell lines. In patient samples, MIR3672 shows the broadest associations at the RNA and protein expression levels, with UCEC recurring as the lineage with the largest associated feature set.
